[ad_1]
In Brazil, which was the first country to complete the trial of the late-stage vaccine called CoronaVac, the announcement of the results first determined in early December was delayed three times at the company’s request. Based on the information obtained, the reason for the delay is the process of collecting and combining all the results of the third phase of the trial.
Officials from the Bhutantan Institute in Sao Paolo claimed that Sinovac wants the results to be announced 15 days later, while Sinopharm, another vaccine developed by China, was in the United Arab Emirates (UAE), on December 9, 31 thousand volunteers out of 125 nations. As a result of the trials, it was announced to be 86 percent effective and the vaccine was approved for widespread use.
coronavac the third phase of the study are participating in Turkey and Indonesia. Indonesia announced that the work is ongoing and the results will be announced in January. Turkey is also expected to announce the results of the third phase soon.
